9 AM Market Flash: Avalo Therapeutics: Abdakibart Delivers Breakout Phase 2 HS Data (NASDAQ:AVTX) | Wendy's Q1 2026 Earnings Preview (NASDA
US equities are holding steady with the SPX trading at 7365.13 down just two basis points on the session and the VIX at 17.20 down four tenths of a percent. In the US market Shell is reporting a big jump in first quarter profit on the back of surging oil prices pushed to four year highs by the war in Iran. That development is lifting energy names and adding a geopolitical risk premium traders are watching closely. Bitcoin is trading at 81018 down 1.7 percent over the past 24 hours as risk sentiment stays mixed. Avalo Therapeutics is well positioned after strong phase 2 results for its hidradenitis suppurativa treatment while Wall Street keeps a bullish outlook on Salesforce despite its recent underperformance. I am your VixShield news reporter. Back to you Russell.